RxDoctor Payments Data

Timothy Rowland, MD

Family Medicine · Hilliard, OHNPI 1629197314

Payments from drug & device makers

$528in general payments, 2019–2025

Across 37 payments — averaging $14.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$74
  • Novo Nordisk$64
  • Johnson & Johnson$55
  • Amgen$41
  • Mylan Specialty L.p.$37
  • Astellas Pharma US Inc$31
  • plus $226 from 12 others

What the payments were for

  • Food & beverage$528100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$528 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$195,340
Medicare patients
331
Services billed
7,560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban109$152,544
OzempicSemaglutide46$59,843
XareltoRivaroxaban43$56,862
JardianceEmpagliflozin21$34,926
WegovySemaglutide14$32,933
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$28,976
JanuviaSitagliptin Phosphate15$24,551
MyrbetriqMirabegron23$14,977
Breo ElliptaFluticasone/Vilanterol13$13,526
VascepaIcosapent Ethyl11$10,486
Janumet XrSitagliptin Phos/Metformin Hcl13$8,789
ShingrixVaricella-Zoster Ge/As01b/Pf39$8,551
Atorvastatin Calcium773$7,160
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf91$6,730
AbrysvoRsv Vacc, Pref A And Pref B/Pf18$6,031

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo, Paxlovid$23$162,801159 claims
Novo NordiskOzempic, Wegovy$64$92,77560 claims
Johnson & JohnsonXarelto$55$56,86243 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$74$51,05377 claims
Boehringer IngelheimJardiance$13$34,92621 claims
Astellas Pharma US IncMyrbetriq$31$14,97723 claims
AbbVieSynthroid$11$3,37853 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Hilliard

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →